EPO CRISPR Patent Appeal Resolved

EPO CRISPR Patent Appeal Resolved

  The EPO Boards of Appeal convened recently to offer a final ruling in respect of EP2771468, a patent granted to the Broad Institute in respect of CRISPR/Cas9 gene editing technology. This case has attracted a lot of attention, not least because of the potential...
New Year, New IP

New Year, New IP

Happy New Year from Albright IP. As we welcome in a new decade, we want to wish all our clients, colleagues and partners around the world a prosperous 2020.   At the turn of the last decade we were just starting out with six staff, today we have expanded not only...